相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling
Jawed A. Siddiqui et al.
BONE (2021)
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
Ramesh Pothuraju et al.
MOLECULAR CANCER (2020)
Sildenafil Potentiates the Therapeutic Efficacy of Docetaxel in Advanced Prostate Cancer by Stimulating NO-cGMP Signaling
Sakthivel Muniyan et al.
CLINICAL CANCER RESEARCH (2020)
Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis
Yanqiu Wang et al.
BMC CANCER (2019)
Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion
Wenchu Wang et al.
ONCOGENE (2019)
FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis
Parthasarathy Seshacharyulu et al.
ONCOGENE (2019)
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
Raghupathy Vengoji et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone
Evelyne Tassone et al.
ONCOGENE (2019)
BK ablation attenuates osteoblast bone formation via integrin pathway
Yinhang Wang et al.
CELL DEATH & DISEASE (2019)
Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
Bridie S. Mulholland et al.
CURRENT OSTEOPOROSIS REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis
Yuta Nakai et al.
BONE RESEARCH (2019)
Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer
Michal Vocka et al.
CANCER BIOMARKERS (2018)
Metastatic Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
Chen Hao Lo et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
Alison B. Shupp et al.
CANCERS (2018)
Non - homeostatic body weight regulation through a brainstem-restricted receptor for GDF15
Jer-Yuan Hsu et al.
NATURE (2017)
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang et al.
NATURE MEDICINE (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson et al.
NATURE MEDICINE (2017)
CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
Jawed Akhtar Siddiqui et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism
Jawed A. Siddiqui et al.
SCIENTIFIC REPORTS (2017)
MIC1/GDF15 as a Bone Metastatic Disease Biomarker
Jindra Windrichova et al.
ANTICANCER RESEARCH (2017)
Skeletal complications in cancer patients with bone metastases
Shunsuke Tsuzuki et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
CD169+ macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer
Andy C. Wu et al.
JOURNAL OF PATHOLOGY (2016)
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
Pierrick G. J. Fournier et al.
CANCER CELL (2015)
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease
Marita Westhrin et al.
HAEMATOLOGICA (2015)
Macrophages: Their Emerging Roles in Bone
Benjamin P. Sinder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer
Murielle Mimeault et al.
ONCOTARGET (2015)
Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease
Marita Westhrin et al.
HAEMATOLOGICA (2015)
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Ramu Adela et al.
JOURNAL OF DIABETES RESEARCH (2015)
Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions
Jinlu Dai et al.
CLINICAL CANCER RESEARCH (2014)
The Anorectic Actions of the TGFβ Cytokine MIC-1/GDF15 Require an Intact Brainstem Area Postrema and Nucleus of the Solitary Tract
Vicky Wang-Wei Tsai et al.
PLOS ONE (2014)
Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1
M. Mimeault et al.
BRITISH JOURNAL OF CANCER (2013)
Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer
Sukhwinder Kaur et al.
PLOS ONE (2013)
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
Xinhai Wan et al.
BONE (2012)
Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model
Zebin Hu et al.
HUMAN GENE THERAPY (2012)
RNAscope A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded Tissues
Fay Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Pathobiological Implications of the Expression of EGFR, pAkt, NF-κB and MIC-1 in Prostate Cancer Stem Cells and Their Progenies
Murielle Mimeault et al.
PLOS ONE (2012)
Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer
Fred Saad et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
TGF-beta in cancer and bone: Implications for treatment of bone metastases
Patricia Juarez et al.
BONE (2011)
A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone
J. A. Siddiqui et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Genetic Ablation of CD68 Results in Mice with Increased Bone and Dysfunctional Osteoclasts
Jason W. Ashley et al.
PLOS ONE (2011)
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs
Ingrid G. Winkler et al.
BLOOD (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Divergent Molecular Mechanisms Underlying the Pleiotropic Functions of Macrophage Inhibitory Cytokine-1 in Cancer
Murielle Mimeault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)
Mette Norgaard et al.
JOURNAL OF UROLOGY (2010)
8,8-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8-biapigeninyl in ovariectomized mice
Jawed A. Siddiqui et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway
S. Senapati et al.
ONCOGENE (2010)
CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
Hernan Roca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Akt promotes BMP2-mediated osteoblast differentiation and bone development
Aditi Mukherjee et al.
JOURNAL OF CELL SCIENCE (2009)
Expression of Macrophage Inhibitory Cytokine-1 in Prostate Cancer Bone Metastases Induces Osteoclast Activation and Weight Loss
Savita Wakchoure et al.
PROSTATE (2009)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo
Ming K. Chang et al.
JOURNAL OF IMMUNOLOGY (2008)
Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats
Ritu Trivedi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Heiko Johnen et al.
NATURE MEDICINE (2007)
Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases
Colm Morrissey et al.
BMC CANCER (2007)
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration
Robert D. Loberg et al.
NEOPLASIA (2007)
Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development
Chunxi Ge et al.
JOURNAL OF CELL BIOLOGY (2007)
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion
Yi Lu et al.
PROSTATE (2006)
Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass
Chao Yang Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
K Brasso et al.
PROSTATE (2006)
GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
J Xu et al.
CIRCULATION RESEARCH (2006)
Prostate cancer cells promote osteoblastic bone metastases through Wnts
CL Hall et al.
CANCER RESEARCH (2005)
Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio
R Kiviranta et al.
BONE (2005)
The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation
TR Kyriakides et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Characterization of C4-2 prostate cancer bone metastases and their response to castration
J Pfitzenmaier et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Dysregulated expression of MIC-1/PDF in human prostate tumor cells
D Karan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The loss of TGF-β signaling promotes prostate cancer metastasis
WH Tu et al.
NEOPLASIA (2003)
Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2
GZ Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells
GZ Xiao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
GZ Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
PTCF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
MJ Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
